0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Receptor ROR Gamma Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-36L6022
Home | Market Reports | Business & Industrial| Energy & Utilities
Global Nuclear Receptor ROR Gamma Market Insights Forecast to 2028
BUY CHAPTERS

Global Nuclear Receptor ROR Gamma Market Research Report 2025

Code: QYRE-Auto-36L6022
Report
September 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nuclear Receptor ROR Gamma Market

The global market for Nuclear Receptor ROR Gamma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Nuclear Receptor ROR Gamma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nuclear Receptor ROR Gamma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Nuclear Receptor ROR Gamma include Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies, Beijing Hanmi Pharmaceutical, Biogen Inc, AbbVie Inc, Eurofins Advinus, Brickell Biotech Inc, Pfizer Inc, Phenex Pharmaceuticals AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Receptor ROR Gamma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Receptor ROR Gamma.
The Nuclear Receptor ROR Gamma market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Receptor ROR Gamma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Receptor ROR Gamma manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nuclear Receptor ROR Gamma Market Report

Report Metric Details
Report Name Nuclear Receptor ROR Gamma Market
Segment by Type
  • BBI-6000
  • GRC-39815Action
  • R&D Progress
  • GSK-2981278
  • IMU-366
  • INV-17
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies, Beijing Hanmi Pharmaceutical, Biogen Inc, AbbVie Inc, Eurofins Advinus, Brickell Biotech Inc, Pfizer Inc, Phenex Pharmaceuticals AG, Reata Pharmaceuticals Inc, Bristol-Myers Squibb Company, Celgene Corp, Eli Lilly, Glenmark Pharmaceuticals, Lead Pharma Holding BV
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nuclear Receptor ROR Gamma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nuclear Receptor ROR Gamma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Nuclear Receptor ROR Gamma Market report?

Ans: The main players in the Nuclear Receptor ROR Gamma Market are Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies, Beijing Hanmi Pharmaceutical, Biogen Inc, AbbVie Inc, Eurofins Advinus, Brickell Biotech Inc, Pfizer Inc, Phenex Pharmaceuticals AG, Reata Pharmaceuticals Inc, Bristol-Myers Squibb Company, Celgene Corp, Eli Lilly, Glenmark Pharmaceuticals, Lead Pharma Holding BV

What are the Application segmentation covered in the Nuclear Receptor ROR Gamma Market report?

Ans: The Applications covered in the Nuclear Receptor ROR Gamma Market report are Chronic Obstructive Pulmonary Disease, Asthma, Axial Spondyloarthritis, Breast Cancer, Others

What are the Type segmentation covered in the Nuclear Receptor ROR Gamma Market report?

Ans: The Types covered in the Nuclear Receptor ROR Gamma Market report are BBI-6000, GRC-39815Action, R&D Progress, GSK-2981278, IMU-366, INV-17, Others

Recommended Reports

Receptor Drug Markets

Gamma Radiation Devices

Oncology Therapeutics

1 Nuclear Receptor ROR Gamma Market Overview
1.1 Product Definition
1.2 Nuclear Receptor ROR Gamma by Type
1.2.1 Global Nuclear Receptor ROR Gamma Market Value Comparison by Type (2024 VS 2031)
1.2.2 BBI-6000
1.2.3 GRC-39815Action
1.2.4 R&D Progress
1.2.5 GSK-2981278
1.2.6 IMU-366
1.2.7 INV-17
1.2.8 Others
1.3 Nuclear Receptor ROR Gamma by Application
1.3.1 Global Nuclear Receptor ROR Gamma Market Value by Application (2024 VS 2031)
1.3.2 Chronic Obstructive Pulmonary Disease
1.3.3 Asthma
1.3.4 Axial Spondyloarthritis
1.3.5 Breast Cancer
1.3.6 Others
1.4 Global Nuclear Receptor ROR Gamma Market Size Estimates and Forecasts
1.4.1 Global Nuclear Receptor ROR Gamma Revenue 2020-2031
1.4.2 Global Nuclear Receptor ROR Gamma Sales 2020-2031
1.4.3 Global Nuclear Receptor ROR Gamma Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nuclear Receptor ROR Gamma Market Competition by Manufacturers
2.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nuclear Receptor ROR Gamma Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nuclear Receptor ROR Gamma, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Receptor ROR Gamma, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Receptor ROR Gamma, Product Type & Application
2.7 Global Key Manufacturers of Nuclear Receptor ROR Gamma, Date of Enter into This Industry
2.8 Global Nuclear Receptor ROR Gamma Market Competitive Situation and Trends
2.8.1 Global Nuclear Receptor ROR Gamma Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nuclear Receptor ROR Gamma Players Market Share by Revenue
2.8.3 Global Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nuclear Receptor ROR Gamma Market Scenario by Region
3.1 Global Nuclear Receptor ROR Gamma Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nuclear Receptor ROR Gamma Sales by Region: 2020-2031
3.2.1 Global Nuclear Receptor ROR Gamma Sales by Region: 2020-2025
3.2.2 Global Nuclear Receptor ROR Gamma Sales by Region: 2026-2031
3.3 Global Nuclear Receptor ROR Gamma Revenue by Region: 2020-2031
3.3.1 Global Nuclear Receptor ROR Gamma Revenue by Region: 2020-2025
3.3.2 Global Nuclear Receptor ROR Gamma Revenue by Region: 2026-2031
3.4 North America Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.4.1 North America Nuclear Receptor ROR Gamma Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nuclear Receptor ROR Gamma Sales by Country (2020-2031)
3.4.3 North America Nuclear Receptor ROR Gamma Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.5.1 Europe Nuclear Receptor ROR Gamma Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nuclear Receptor ROR Gamma Sales by Country (2020-2031)
3.5.3 Europe Nuclear Receptor ROR Gamma Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Receptor ROR Gamma Market Facts & Figures by Region
3.6.1 Asia Pacific Nuclear Receptor ROR Gamma Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nuclear Receptor ROR Gamma Sales by Region (2020-2031)
3.6.3 Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.7.1 Latin America Nuclear Receptor ROR Gamma Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nuclear Receptor ROR Gamma Sales by Country (2020-2031)
3.7.3 Latin America Nuclear Receptor ROR Gamma Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Receptor ROR Gamma Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Receptor ROR Gamma Sales by Type (2020-2031)
4.1.1 Global Nuclear Receptor ROR Gamma Sales by Type (2020-2025)
4.1.2 Global Nuclear Receptor ROR Gamma Sales by Type (2026-2031)
4.1.3 Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2020-2031)
4.2 Global Nuclear Receptor ROR Gamma Revenue by Type (2020-2031)
4.2.1 Global Nuclear Receptor ROR Gamma Revenue by Type (2020-2025)
4.2.2 Global Nuclear Receptor ROR Gamma Revenue by Type (2026-2031)
4.2.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2020-2031)
4.3 Global Nuclear Receptor ROR Gamma Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nuclear Receptor ROR Gamma Sales by Application (2020-2031)
5.1.1 Global Nuclear Receptor ROR Gamma Sales by Application (2020-2025)
5.1.2 Global Nuclear Receptor ROR Gamma Sales by Application (2026-2031)
5.1.3 Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2020-2031)
5.2 Global Nuclear Receptor ROR Gamma Revenue by Application (2020-2031)
5.2.1 Global Nuclear Receptor ROR Gamma Revenue by Application (2020-2025)
5.2.2 Global Nuclear Receptor ROR Gamma Revenue by Application (2026-2031)
5.2.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2020-2031)
5.3 Global Nuclear Receptor ROR Gamma Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Genfit SA
6.1.1 Genfit SA Company Information
6.1.2 Genfit SA Description and Business Overview
6.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Genfit SA Nuclear Receptor ROR Gamma Product Portfolio
6.1.5 Genfit SA Recent Developments/Updates
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Company Information
6.2.2 GlaxoSmithKline Plc Description and Business Overview
6.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio
6.2.5 GlaxoSmithKline Plc Recent Developments/Updates
6.3 Aurigene Discovery Technologies
6.3.1 Aurigene Discovery Technologies Company Information
6.3.2 Aurigene Discovery Technologies Description and Business Overview
6.3.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio
6.3.5 Aurigene Discovery Technologies Recent Developments/Updates
6.4 Beijing Hanmi Pharmaceutical
6.4.1 Beijing Hanmi Pharmaceutical Company Information
6.4.2 Beijing Hanmi Pharmaceutical Description and Business Overview
6.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio
6.4.5 Beijing Hanmi Pharmaceutical Recent Developments/Updates
6.5 Biogen Inc
6.5.1 Biogen Inc Company Information
6.5.2 Biogen Inc Description and Business Overview
6.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio
6.5.5 Biogen Inc Recent Developments/Updates
6.6 AbbVie Inc
6.6.1 AbbVie Inc Company Information
6.6.2 AbbVie Inc Description and Business Overview
6.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio
6.6.5 AbbVie Inc Recent Developments/Updates
6.7 Eurofins Advinus
6.7.1 Eurofins Advinus Company Information
6.7.2 Eurofins Advinus Description and Business Overview
6.7.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio
6.7.5 Eurofins Advinus Recent Developments/Updates
6.8 Brickell Biotech Inc
6.8.1 Brickell Biotech Inc Company Information
6.8.2 Brickell Biotech Inc Description and Business Overview
6.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio
6.8.5 Brickell Biotech Inc Recent Developments/Updates
6.9 Pfizer Inc
6.9.1 Pfizer Inc Company Information
6.9.2 Pfizer Inc Description and Business Overview
6.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio
6.9.5 Pfizer Inc Recent Developments/Updates
6.10 Phenex Pharmaceuticals AG
6.10.1 Phenex Pharmaceuticals AG Company Information
6.10.2 Phenex Pharmaceuticals AG Description and Business Overview
6.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio
6.10.5 Phenex Pharmaceuticals AG Recent Developments/Updates
6.11 Reata Pharmaceuticals Inc
6.11.1 Reata Pharmaceuticals Inc Company Information
6.11.2 Reata Pharmaceuticals Inc Description and Business Overview
6.11.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio
6.11.5 Reata Pharmaceuticals Inc Recent Developments/Updates
6.12 Bristol-Myers Squibb Company
6.12.1 Bristol-Myers Squibb Company Company Information
6.12.2 Bristol-Myers Squibb Company Description and Business Overview
6.12.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio
6.12.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.13 Celgene Corp
6.13.1 Celgene Corp Company Information
6.13.2 Celgene Corp Description and Business Overview
6.13.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio
6.13.5 Celgene Corp Recent Developments/Updates
6.14 Eli Lilly
6.14.1 Eli Lilly Company Information
6.14.2 Eli Lilly Description and Business Overview
6.14.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio
6.14.5 Eli Lilly Recent Developments/Updates
6.15 Glenmark Pharmaceuticals
6.15.1 Glenmark Pharmaceuticals Company Information
6.15.2 Glenmark Pharmaceuticals Description and Business Overview
6.15.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio
6.15.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.16 Lead Pharma Holding BV
6.16.1 Lead Pharma Holding BV Company Information
6.16.2 Lead Pharma Holding BV Description and Business Overview
6.16.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio
6.16.5 Lead Pharma Holding BV Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Receptor ROR Gamma Industry Chain Analysis
7.2 Nuclear Receptor ROR Gamma Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Receptor ROR Gamma Production Mode & Process Analysis
7.4 Nuclear Receptor ROR Gamma Sales and Marketing
7.4.1 Nuclear Receptor ROR Gamma Sales Channels
7.4.2 Nuclear Receptor ROR Gamma Distributors
7.5 Nuclear Receptor ROR Gamma Customer Analysis
8 Nuclear Receptor ROR Gamma Market Dynamics
8.1 Nuclear Receptor ROR Gamma Industry Trends
8.2 Nuclear Receptor ROR Gamma Market Drivers
8.3 Nuclear Receptor ROR Gamma Market Challenges
8.4 Nuclear Receptor ROR Gamma Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nuclear Receptor ROR Gamma Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nuclear Receptor ROR Gamma Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nuclear Receptor ROR Gamma Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nuclear Receptor ROR Gamma Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nuclear Receptor ROR Gamma Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nuclear Receptor ROR Gamma, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nuclear Receptor ROR Gamma, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nuclear Receptor ROR Gamma, Product Type & Application
 Table 12. Global Key Manufacturers of Nuclear Receptor ROR Gamma, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nuclear Receptor ROR Gamma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Receptor ROR Gamma as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nuclear Receptor ROR Gamma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nuclear Receptor ROR Gamma Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2020-2025)
 Table 19. Global Nuclear Receptor ROR Gamma Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2026-2031)
 Table 21. Global Nuclear Receptor ROR Gamma Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2020-2025)
 Table 23. Global Nuclear Receptor ROR Gamma Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2026-2031)
 Table 25. North America Nuclear Receptor ROR Gamma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nuclear Receptor ROR Gamma Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Nuclear Receptor ROR Gamma Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Nuclear Receptor ROR Gamma Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nuclear Receptor ROR Gamma Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nuclear Receptor ROR Gamma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nuclear Receptor ROR Gamma Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Nuclear Receptor ROR Gamma Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Nuclear Receptor ROR Gamma Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nuclear Receptor ROR Gamma Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nuclear Receptor ROR Gamma Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Nuclear Receptor ROR Gamma Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nuclear Receptor ROR Gamma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nuclear Receptor ROR Gamma Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Nuclear Receptor ROR Gamma Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Nuclear Receptor ROR Gamma Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nuclear Receptor ROR Gamma Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2020-2025)
 Table 53. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2026-2031)
 Table 54. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2020-2025)
 Table 57. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2026-2031)
 Table 58. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2020-2025)
 Table 63. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2026-2031)
 Table 64. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2020-2025)
 Table 67. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2026-2031)
 Table 68. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2026-2031)
 Table 70. Genfit SA Company Information
 Table 71. Genfit SA Description and Business Overview
 Table 72. Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Genfit SA Nuclear Receptor ROR Gamma Product
 Table 74. Genfit SA Recent Developments/Updates
 Table 75. GlaxoSmithKline Plc Company Information
 Table 76. GlaxoSmithKline Plc Description and Business Overview
 Table 77. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product
 Table 79. GlaxoSmithKline Plc Recent Developments/Updates
 Table 80. Aurigene Discovery Technologies Company Information
 Table 81. Aurigene Discovery Technologies Description and Business Overview
 Table 82. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product
 Table 84. Aurigene Discovery Technologies Recent Developments/Updates
 Table 85. Beijing Hanmi Pharmaceutical Company Information
 Table 86. Beijing Hanmi Pharmaceutical Description and Business Overview
 Table 87. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product
 Table 89. Beijing Hanmi Pharmaceutical Recent Developments/Updates
 Table 90. Biogen Inc Company Information
 Table 91. Biogen Inc Description and Business Overview
 Table 92. Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Biogen Inc Nuclear Receptor ROR Gamma Product
 Table 94. Biogen Inc Recent Developments/Updates
 Table 95. AbbVie Inc Company Information
 Table 96. AbbVie Inc Description and Business Overview
 Table 97. AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. AbbVie Inc Nuclear Receptor ROR Gamma Product
 Table 99. AbbVie Inc Recent Developments/Updates
 Table 100. Eurofins Advinus Company Information
 Table 101. Eurofins Advinus Description and Business Overview
 Table 102. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Eurofins Advinus Nuclear Receptor ROR Gamma Product
 Table 104. Eurofins Advinus Recent Developments/Updates
 Table 105. Brickell Biotech Inc Company Information
 Table 106. Brickell Biotech Inc Description and Business Overview
 Table 107. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product
 Table 109. Brickell Biotech Inc Recent Developments/Updates
 Table 110. Pfizer Inc Company Information
 Table 111. Pfizer Inc Description and Business Overview
 Table 112. Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Pfizer Inc Nuclear Receptor ROR Gamma Product
 Table 114. Pfizer Inc Recent Developments/Updates
 Table 115. Phenex Pharmaceuticals AG Company Information
 Table 116. Phenex Pharmaceuticals AG Description and Business Overview
 Table 117. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product
 Table 119. Phenex Pharmaceuticals AG Recent Developments/Updates
 Table 120. Reata Pharmaceuticals Inc Company Information
 Table 121. Reata Pharmaceuticals Inc Description and Business Overview
 Table 122. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product
 Table 124. Reata Pharmaceuticals Inc Recent Developments/Updates
 Table 125. Bristol-Myers Squibb Company Company Information
 Table 126. Bristol-Myers Squibb Company Description and Business Overview
 Table 127. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product
 Table 129. Bristol-Myers Squibb Company Recent Developments/Updates
 Table 130. Celgene Corp Company Information
 Table 131. Celgene Corp Description and Business Overview
 Table 132. Celgene Corp Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Celgene Corp Nuclear Receptor ROR Gamma Product
 Table 134. Celgene Corp Recent Developments/Updates
 Table 135. Eli Lilly Company Information
 Table 136. Eli Lilly Description and Business Overview
 Table 137. Eli Lilly Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Eli Lilly Nuclear Receptor ROR Gamma Product
 Table 139. Eli Lilly Recent Developments/Updates
 Table 140. Glenmark Pharmaceuticals Company Information
 Table 141. Glenmark Pharmaceuticals Description and Business Overview
 Table 142. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product
 Table 144. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 145. Lead Pharma Holding BV Company Information
 Table 146. Lead Pharma Holding BV Description and Business Overview
 Table 147. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product
 Table 149. Lead Pharma Holding BV Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Nuclear Receptor ROR Gamma Distributors List
 Table 153. Nuclear Receptor ROR Gamma Customers List
 Table 154. Nuclear Receptor ROR Gamma Market Trends
 Table 155. Nuclear Receptor ROR Gamma Market Drivers
 Table 156. Nuclear Receptor ROR Gamma Market Challenges
 Table 157. Nuclear Receptor ROR Gamma Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nuclear Receptor ROR Gamma
 Figure 2. Global Nuclear Receptor ROR Gamma Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nuclear Receptor ROR Gamma Market Share by Type: 2024 & 2031
 Figure 4. BBI-6000 Product Picture
 Figure 5. GRC-39815Action Product Picture
 Figure 6. R&D Progress Product Picture
 Figure 7. GSK-2981278 Product Picture
 Figure 8. IMU-366 Product Picture
 Figure 9. INV-17 Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Nuclear Receptor ROR Gamma Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Nuclear Receptor ROR Gamma Market Share by Application: 2024 & 2031
 Figure 13. Chronic Obstructive Pulmonary Disease
 Figure 14. Asthma
 Figure 15. Axial Spondyloarthritis
 Figure 16. Breast Cancer
 Figure 17. Others
 Figure 18. Global Nuclear Receptor ROR Gamma Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Nuclear Receptor ROR Gamma Market Size (2020-2031) & (US$ Million)
 Figure 20. Global Nuclear Receptor ROR Gamma Sales (2020-2031) & (K Pcs)
 Figure 21. Global Nuclear Receptor ROR Gamma Average Price (USD/Pcs) & (2020-2031)
 Figure 22. Nuclear Receptor ROR Gamma Report Years Considered
 Figure 23. Nuclear Receptor ROR Gamma Sales Share by Manufacturers in 2024
 Figure 24. Global Nuclear Receptor ROR Gamma Revenue Share by Manufacturers in 2024
 Figure 25. Global 5 and 10 Largest Nuclear Receptor ROR Gamma Players: Market Share by Revenue in Nuclear Receptor ROR Gamma in 2024
 Figure 26. Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Global Nuclear Receptor ROR Gamma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 28. North America Nuclear Receptor ROR Gamma Sales Market Share by Country (2020-2031)
 Figure 29. North America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2020-2031)
 Figure 30. U.S. Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Canada Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country (2020-2031)
 Figure 33. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Country (2020-2031)
 Figure 34. Germany Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. France Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. U.K. Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Italy Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Russia Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Region (2020-2031)
 Figure 40. Asia Pacific Nuclear Receptor ROR Gamma Revenue Market Share by Region (2020-2031)
 Figure 41. China Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Japan Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. South Korea Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. India Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Australia Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Taiwan Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Indonesia Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Thailand Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Malaysia Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Philippines Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Latin America Nuclear Receptor ROR Gamma Sales Market Share by Country (2020-2031)
 Figure 52. Latin America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2020-2031)
 Figure 53. Mexico Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Brazil Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Argentina Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Market Share by Country (2020-2031)
 Figure 58. Turkey Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Saudi Arabia Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. UAE Nuclear Receptor ROR Gamma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Global Sales Market Share of Nuclear Receptor ROR Gamma by Type (2020-2031)
 Figure 62. Global Revenue Market Share of Nuclear Receptor ROR Gamma by Type (2020-2031)
 Figure 63. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2020-2031)
 Figure 64. Global Sales Market Share of Nuclear Receptor ROR Gamma by Application (2020-2031)
 Figure 65. Global Revenue Market Share of Nuclear Receptor ROR Gamma by Application (2020-2031)
 Figure 66. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2020-2031)
 Figure 67. Nuclear Receptor ROR Gamma Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Big Data in Oil and Gas Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2W8991
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global High-Purity Water Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9I6226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global E-Methanol Fuel for Marine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34Z16832
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Grid Optimization Solutions Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B6087
Fri Sep 12 00:00:00 UTC 2025

Add to Cart